The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDewhurst Regulatory News (DWHT)

Share Price Information for Dewhurst (DWHT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,150.00
Bid: 1,100.00
Ask: 1,200.00
Change: 25.00 (2.22%)
Spread: 100.00 (9.091%)
Open: 1,125.00
High: 1,150.00
Low: 1,085.00
Prev. Close: 1,125.00
DWHT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

26 Jun 2023 07:00

RNS Number : 7864D
Dewhurst Group PLC
26 June 2023
 

 

Dewhurst Group plc

 

Interim Results for the 6 months ended 31 March 2023

 

Directors' Interim Report

 

FIRST HALF

The Group is rising to challenges presented by the new inflationary environment in all our major markets. We are pleased to report improved results with increased profit before tax and revenue figures for the first half of the current financial year, but lower margins on sales. Overall, Group revenue increased by 12% to £30.4 million (2022: £27.1 million) and operating profit increased 4% to £4.0 million (2022: £3.8 million), while profit before tax increased 8% to £4.0 million (2022: £3.7 million) and earnings per share improved to 32.1p (2022: 28.4p). First half currency movements increased Group revenue and profit by 4%.

 

Lift Division sales grew in most regions, led by a strong performance in Canada and the USA, but the lull in major projects in Sydney continued through the first half. There was a modest recovery in Keypad sales, but these continue to be quite volatile and unpredictable from month to month. Overall Transport sales were fairly similar to the previous year, but rail infrastructure spending was down offset by a strong performance on highways products.

 

The Group balance sheet remains strong with cash at the period end of £22.6 million (2022: £19.9 million).

 

OUTLOOK

In North America the underlying market remains strong, although there are signs that the second half of this financial year may be impacted by a slowing of orders and customer approvals to proceed. Orders in Australia are reasonable, but we are still expecting it will take time for these orders to filter through to sales as continuing customer labour constraints are leading to some project delays. The UK has remained surprisingly steady given the economic backdrop, but may tail off later in the year as the impact of interest rate rises start to bite on the economy. We have better control this year on dealing with cost increases and all companies are focussed on trying to mitigate their impact. However, we are not able to pass all increases on to customers, so we are continuing to see margins squeezed. Recruitment challenges have eased a little in most of our markets and material availability has improved. As a result we have been able to reduce our abnormally high stock holdings, without a detrimental effect on service levels.

 

DIVIDENDS

The Directors have declared an increased interim dividend of 4.75p per ordinary share (2022: 4.50p) which amounts to £384,000 (2022: £364,000). The interim dividend is payable on 15 August 2023 and will be posted on 10 August 2023 to shareholders appearing in the Register on 7 July 2023 (ex-dividend date being 6 July 2023).

 

A final 2022 dividend of 10.25p (2021: 9.75p) which amounted to £828,000 (2021: £788,000) was approved at the AGM held on 14 February 2023 and was paid on 22 February 2023 to members on the register at 20 January 2023.

 

By Order of the Board

 

J C SINCLAIR

Chief Financial Officer & Secretary

23 June 2023

Dewhurst Group plc

 

The unaudited consolidated statement of comprehensive income, statement of financial position, statement of changes in equity and cash flow statement of Dewhurst Group plc and its subsidiaries for the half-year ended 31 March 2023, as compared with the corresponding half-year ended 31 March 2022 and the year ended 30 September 2022, shows the following results:

 

Consolidated statement of comprehensive income

Half year

Half year

Year

ended

ended

ended

31 March

31 March

30 Sept

2023

2022

2022

Continuing operations

£000's

£000's

£000's

 

Revenue

30,379

27,050

57,565

Operating costs

(26,423)

(23,232)

(50,269)

Adjusted operating profit

3,956

3,818

8,818

Cyber attack remediation costs

-

-

(1,522)

Operating profit

3,956

3,818

7,296

Finance income

181

12

64

Finance costs

(95)

(102)

(191)

Profit before taxation

4,042

3,728

7,169

Taxation

Est. (1,448)

Est. (1,436)

(2,051)

Profit for the financial period

2,594

2,292

5,118

 

Other comprehensive income:

 

Actuarial gains/(losses) on the defined benefit pension scheme

Est. (1,453)

Est. 3,879

1,887

Deferred tax effect

363

(970)

(472)

Current tax effect

 Est. 218

Est. 159

200

Total that will not be subsequently reclassified to income statement

(872)

3,068

1,615

 

Exchange differences on translation of foreign operations

(3,236)

1,414

3,563

Total that may be subsequently reclassified to income statement

(3,236)

1,414

3,563

Other comprehensive income/(expense) for the period, net of tax

(4,108)

4,482

5,178

Total comprehensive income for the period

(1,514)

6,774

10,296

 

Profit for the period attributable to:

 

Equity shareholders of the company

2,532

2,179

4,849

Non-controlling interests

62

113

269

2,594

2,292

5,118

 

Total comprehensive income for the period attributable to:

 

Equity shareholders of the company

(1,425)

6,578

9,867

Non-controlling interests

(89)

196

429

(1,514)

6,774

10,296

 

Basic and diluted earnings per share

32.10p

28.36p

60.00p

Dividends per share

4.75p

4.50p

14.75p

 

 

Dewhurst Group plc

 

Consolidated statement of financial position

Half year

Half year

Year

ended

ended

ended

31 March

31 March

30 Sept

 

2023

2022

2022

 

£000's

£000's

£000's

Non-current assets

 

Goodwill

9,672

9,890

10,105

Other intangibles

17

24

19

Property, plant and equipment

17,573

18,207

19,147

Right-of-use assets

2,159

2,625

2,473

Deferred tax asset

262

-

118

29,683

30,746

31,862

 

Current assets

 

Inventories

7,377

7,011

7,931

Trade and other receivables

12,475

12,116

12,318

Current tax asset

-

-

281

Cash and cash equivalents

22,590

19,854

21,764

42,442

38,981

42,294

Total assets

72,125

69,727

74,156

 

Current liabilities

 

Trade and other payables

7,618

7,703

7,783

Current tax liabilities

319

156

-

Short-term provisions

343

344

344

Lease liabilities

501

470

505

8,781

8,673

8,632

Non-current liabilities

 

Retirement benefit obligation

2,377

219

1,798

Deferred tax liabilities

-

10

-

Lease liabilities

1,894

2,359

2,193

Total liabilities

13,052

11,261

12,623

Net assets

59,073

58,466

61,533

 

Equity

 

Share capital

808

808

808

Share premium account

157

157

157

Capital redemption reserve

329

329

329

Translation reserve

1,980

2,992

5,065

Retained earnings

54,357

52,672

53,525

Total attributable to equity shareholders of the company

57,631

56,958

59,884

Non-controlling interests

1,442

1,508

1,649

Total equity

59,073

58,466

61,533

 

 

 

Dewhurst Group plc

 

Consolidated statement of changes in equity

 

For the period ended 31 March 2023

 

 

 

 

 

 

 

 

 

Share

Share

Capital

Translation

Retained

Non

Total

 

capital

premium

redemption

reserve

earnings

controlling

equity

 

 

account

reserve

 

 

interest

 

 

£(000)

£(000)

£(000)

£(000)

£(000)

£(000)

£(000)

 

 

 

 

 

 

 

 

At 30 September 2022

808

157

329

5,065

53,525

1,649

61,533

Exchange differences on

translation of foreign operations

 

-

 

-

 

-

 

(3,085)

 

-

 

(151)

 

(3,236)

Actuarial gains/(losses) on defined benefit pension scheme

 

-

 

-

 

-

 

-

 

(1,453)

 

-

 

(1,453)

Deferred tax effect

-

-

-

-

363

-

363

Tax on items taken directly to equity (Est.)

 

-

 

-

 

-

 

-

 

218

 

-

 

218

Dividends paid

-

-

-

-

(828)

(118)

(946)

Profit for the period

-

-

-

-

2,532

62

2,594

 

 

 

 

 

 

 

 

At 31 March 2023

808

157

329

1,980

54,357

1,442

59,073

 

For the period ended 31 March 2022

Share

Share

Capital

Translation

Retained

Non

Total

capital

premium

redemption

reserve

earnings

controlling

equity

account

reserve

interest

£(000)

£(000)

£(000)

£(000)

£(000)

£(000)

£(000)

At 30 September 2021

808

157

329

1,662

48,213

1,562

52,731

Exchange differences on

translation of foreign operations

 

-

 

-

 

-

 

1,330

 

-

 

84

 

1,414

Actuarial gains/(losses) on defined benefit pension scheme

 

-

 

-

 

-

 

-

 

3,879

 

-

 

3,879

Deferred tax effect

-

-

-

-

(970)

-

(970)

Tax on items taken directly to equity (Est.)

 

-

 

-

 

-

 

-

 

159

 

-

 

159

Dividends paid

-

-

-

-

(788)

(251)

(1,039)

Profit for the period

-

-

-

-

2,179

113

2,292

At 31 March 2022

808

157

329

2,992

52,672

1,508

58,466

 

 

Dewhurst Group plc

 

Consolidated statement of changes in equity (cont'd)

 

For the year ended 30 September 2022

 

 

Share

Share

Capital

Translation

Retained

Non

Total

capital

premium

redemption

reserve

earnings

controlling

equity

account

reserve

interest

£(000)

£(000)

£(000)

£(000)

£(000)

£(000)

£(000)

 

 

At 30 September 2021

808

157

329

1,662

48,213

1,562

52,731

Exchange differences on

translation of foreign operations

 

-

 

-

 

-

 

3,403

 

-

 

160

 

3,563

Actuarial gains/(losses) on defined benefit pension scheme

 

-

 

-

 

-

 

-

 

1,887

 

-

 

1,887

Deferred tax effect

-

-

-

-

(472)

-

(472)

Tax on items taken directly to equity

 

-

 

-

 

-

 

-

 

200

 

-

 

200

Dividends paid

-

-

-

-

(1,152)

(342)

(1,494)

Profit for the year

-

-

-

-

4,849

269

5,118

At 30 September 2022

808

157

329

5,065

53,525

1,649

61,533

 

 

 

These half-year abbreviated financial statements are unaudited and do not constitute statutory accounts within the meaning of Section 435 of the Companies Act 2006. The results for the year ended 30 September 2022 set out above are abridged. Full accounts for that year reported under IFRS, on which the auditors of the Company made an unqualified report have been delivered to the Registrar of Companies.

 

The presentation of these Interim Financial Statements is consistent with the 2022 Financial Statements and its accounting policies, but where necessary comparative information has been reclassified or expanded from the 2022 Interim Financial Statements to take into account any presentational changes made in the 2022 Financial Statements or in these Interim Financial Statements.

 

 

 

Dewhurst Group plc

 

Consolidated cash flow statement

Half year

Half year

Year

ended

ended

ended

31 March

31 March

30 Sept

 

2023

2022

2022

 

£000's

£000's

£000's

Cash flows from operating activities

 

Operating profit

3,956

3,818

7,296

Depreciation and amortisation

533

510

1,050

Right-of-use asset depreciation

251

238

509

Additional contributions to pension scheme

(919)

(683)

(1,137)

Exchange adjustments

(759)

240

738

(Profit)/loss on disposal of property, plant and equipment

(17)

(1)

(13)

3,045

4,122

8,443

(Increase)/decrease in inventories

554

(414)

(1,334)

(Increase)/decrease in trade and other receivables

(157)

(2,108)

(2,310)

Increase/(decrease) in trade and other payables

(165)

132

212

Increase/(decrease) in provisions

(1)

1

1

Cash generated from operations

3,276

1,733

5,012

Interest paid

-

-

(1)

Tax paid

(398)

(1,031)

(1,712)

Net cash from operating activities

2,878

702

3,299

 

Cash flows from investing activities

 

Proceeds from sale of property, plant and equipment

28

10

23

Purchase of property, plant and equipment

(298)

(309)

(789)

Development costs capitalised

-

-

(5)

Interest received

181

12

64

Net cash generated from/(used in) investing activities

(89)

(287)

(707)

 

Cash flows from financing activities

 

Dividends paid

(946)

(1,039)

(1,494)

Repayment of lease liabilities including interest

(291)

(277)

(584)

Net cash used in financing activities

(1,237)

(1,316)

(2,078)

 

Net increase/(decrease) in cash and cash equivalents

1,552

(901)

514

Cash and cash equivalents at beginning of period

21,764

20,463

20,463

Exchange adjustments on cash and cash equivalents

(726)

292

787

Cash and cash equivalents at end of period

22,590

19,854

21,764

 

 

Contacts:

 

Dewhurst Group Plc Tel: +44 (0)208 744 8200

Richard Dewhurst, Chairman

Jared Sinclair, Chief Financial Officer

www.dewhurst-group.com

 

Singer Capital Markets (Nominated Adviser and Sole Broker) Tel: +44 (0)207 496 3000

Rick Thompson / Alex Bond / James Fischer

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR ZXLFLXQLXBBF
Date   Source Headline
28th Mar 20247:00 amRNSTransaction in Own Shares and Buyback Update
27th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20246:10 pmRNSAIM Rule 17 Schedule Two (g) Update
26th Feb 20247:00 amRNSHolding(s) in Company
23rd Feb 20248:33 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSAcquisition of Minority Interest in P&R Liftcars
20th Feb 20244:32 pmRNSResult of AGM
9th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSHolding(s) in Company
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSShare Buyback Programme
1st Feb 20247:00 amRNSHolding(s) in Company
18th Jan 20244:45 pmRNSHolding(s) in Company
12th Jan 202411:31 amRNSHolding(s) in Company
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSPreliminary Results
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSDirector / PCA Dealing
29th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSDisplays and Position Indicators
26th Jun 20237:00 amRNSInterim Results
14th Feb 20235:07 pmRNSResult of AGM
14th Dec 20221:14 pmRNSDirector / PDMR Dealing
8th Dec 20227:00 amRNSPreliminary Results
12th Jul 20227:00 amRNSAppointment of Chief Executive Officer
15th Jun 202211:51 amRNSDirector / PDMR Dealing
15th Jun 20227:00 amRNSInterim Results
1st Jun 20227:00 amRNSCyber Incident
1st Mar 20227:00 amRNSChange of Company Name
15th Feb 20224:56 pmRNSResult of AGM and GM
28th Jan 20227:00 amRNSNotice of General Meeting, Proposed Name Change
12th Jan 202211:05 amRNSSecond Price Monitoring Extn
12th Jan 202211:00 amRNSPrice Monitoring Extension
8th Dec 20217:00 amRNSPreliminary Results
8th Jul 20214:33 pmRNSDirector/PDMR Shareholding
15th Jun 20214:46 pmRNSDirector / PDMR Dealing
9th Jun 20218:00 amRNSAppointment of Non-Executive Directors
9th Jun 20217:00 amRNSInterim Results
16th Feb 202112:00 pmRNSResult of AGM
1st Feb 20217:00 amRNSBoard Changes
13th Jan 202111:51 amRNSPosting of Annual Report and Notice of AGM
9th Dec 20207:00 amRNSPreliminary Results
30th Jul 20207:00 amRNSChange of Adviser
3rd Jul 20204:47 pmRNSTransaction in Own Shares
26th Jun 202012:00 pmRNSDirector Resignation
4th Jun 20207:00 amRNSInterim Results
31st Mar 20207:00 amRNSCOVID-19 Trading Update
18th Feb 20204:02 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.